Bupropion Hydrochloride
- Product NDC
- 70934-125
- 11-digit product format
- 709340125
- Labeler code
- 70934
- Product ID
- 70934-125_e39d890c-967f-3e2c-e053-2a95a90aa3f3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA090693
- Marketing category
- ANDA
- Marketing start
- 2022-07-06
- Marketing end
- 2024-04-30
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| ZG7E5POY8O | BUPROPION HYDROCHLORIDE | 31677-93-7 | BUPROPION HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-125-90 | 70934012590 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-125-90) | 2022-07-06 | 2024-02-29 | No | No | Current |
| 70934-125-96 | 70934012596 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-125-96) | 2022-07-07 | 2024-04-30 | No | No | Current |